Literature DB >> 17446108

Correlates for disease progression and prognosis during concurrent HIV/TB infection.

Joel Fleury Djoba Siawaya1, Morten Ruhwald, Jesper Eugen-Olsen, Gerhard Walzl.   

Abstract

Mycobacterium tuberculosis (Mtb) and the human immunodeficiency virus (HIV) are both life-threatening pathogens in their own right, but their synergic effects on the immune system during co-infection markedly enhance their effect on the host. This review focuses on the bidirectional interaction between HIV and Mtb and discusses the relevance of sputum smear examination, CD4+ counts, viral load at baseline and after initiation of anti-retroviral therapy, as well as additional existing and new potential immune correlates of disease progression and prognosis. These markers include beta2-microglobulin, neopterin, tumor necrosis factor receptor II (TNFRII), CD8+/CD38+, soluble urokinase plasminogen activator receptor (suPAR) and CXCL10 (or IP-10).

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17446108     DOI： 10.1016/j.ijid.2007.02.001

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN： 1201-9712            Impact factor:   3.623


  24 in total

1.  High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala.

Authors:  Blanca Samayoa; Monika Roy; Angela Ahlquist Cleveland; Narda Medina; Dalia Lau-Bonilla; Christina M Scheel; Beatriz L Gomez; Tom Chiller; Eduardo Arathoon
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

2.  Using novel methods to examine stress among HIV-positive African American men who have sex with men and women.

Authors:  Dorie A Glover; John K Williams; Kimberly A Kisler
Journal:  J Behav Med       Date:  2012-04-27

Review 3.  Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

Authors:  Paul K Drain; Kristina L Bajema; David Dowdy; Keertan Dheda; Kogieleum Naidoo; Samuel G Schumacher; Shuyi Ma; Erin Meermeier; David M Lewinsohn; David R Sherman
Journal:  Clin Microbiol Rev       Date:  2018-07-18       Impact factor: 26.132

4.  Simian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation.

Authors:  Joshua T Mattila; Collin R Diedrich; Philana Ling Lin; Jiayao Phuah; JoAnne L Flynn
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

Review 5.  Understanding latent tuberculosis: a moving target.

Authors:  Philana Ling Lin; Joanne L Flynn
Journal:  J Immunol       Date:  2010-07-01       Impact factor: 5.422

6.  Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions.

Authors:  David M Scollard; Meher V Chaduvula; Alejandra Martinez; Natalie Fowlkes; Indira Nath; Barbara M Stryjewska; Michael T Kearney; Diana L Williams
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

Review 7.  Immunological biomarkers of tuberculosis.

Authors:  Gerhard Walzl; Katharina Ronacher; Willem Hanekom; Thomas J Scriba; Alimuddin Zumla
Journal:  Nat Rev Immunol       Date:  2011-04-08       Impact factor: 53.106

8.  Incident tuberculosis and risk factors among HIV-infected children in Tanzania.

Authors:  Nan Li; Karim P Manji; Donna Spiegelman; Aisa Muya; Ramadhani S Mwiru; Enju Liu; Guerino Chalamilla; Wafaie W Fawzi; Christopher Duggan
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

9.  A sexual risk and stress reduction intervention designed for HIV-positive bisexual African American men with childhood sexual abuse histories.

Authors:  John K Williams; Dorie A Glover; Gail E Wyatt; Kimberly Kisler; Honghu Liu; Muyu Zhang
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

10.  Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.

Authors:  Cormac Cosgrove; James E Ussher; Andri Rauch; Kathleen Gärtner; Ayako Kurioka; Michael H Hühn; Krista Adelmann; Yu-Hoi Kang; Joannah R Fergusson; Peter Simmonds; Philip Goulder; Ted H Hansen; Julie Fox; Huldrych F Günthard; Nina Khanna; Fiona Powrie; Alan Steel; Brian Gazzard; Rodney E Phillips; John Frater; Holm Uhlig; Paul Klenerman
Journal:  Blood       Date:  2012-12-18       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.